Onconic Therapeutics Inc. (KOSDAQ:476060)

South Korea · Delayed Price · Currency is KRW

12,390

+280 (2.31%)

Nov 2, 2026, 3:30 PM KST

Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	562,603	869,777	176,537	-	-	-
Market Cap Growth	-31.95%	392.69%	-	-	-	-
Enterprise Value	500,258	816,363	152,373	-	-	-
Last Close Price	12110.00	19550.00	4085.00	-	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	23.44	55.11	-	-	-	-
PS Ratio	6.69	16.29	11.90	-	-	-
PB Ratio	6.41	12.07	3.15	-	-	-
P/TBV Ratio	6.41	12.07	3.15	-	-	-
P/FCF Ratio	33.35	78.41	-	-	-	-
P/OCF Ratio	32.72	76.33	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	5.93	15.29	10.27	-	-	-
EV/EBITDA Ratio	27.28	62.09	-	-	-	-
EV/EBIT Ratio	28.18	64.69	-	-	-	-
EV/FCF Ratio	29.57	73.60	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.01	-0.06	0.00	-0.02
Debt / EBITDA Ratio	0.02	0.01	-	0.13	-	-
Debt / FCF Ratio	0.02	0.01	-	0.12	-	-
Net Debt / Equity Ratio	-0.73	-0.73	-0.76	5.05	1.24	2.34
Net Debt / EBITDA Ratio	-3.49	-4.00	9.82	-11.05	1.85	2.25
Net Debt / FCF Ratio	-3.78	-4.74	5.35	-9.97	1.56	2.11
Asset Turnover	1.05	0.78	0.30	0.62	0.00	-
Quick Ratio	11.32	17.48	10.61	0.71	1.06	36.08
Current Ratio	11.39	17.62	10.94	0.71	1.06	36.10
Return on Equity (ROE)	33.51%	24.65%	-32.29%	-	-	-
Return on Assets (ROA)	13.81%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	20.10%	17.50%	-8.50%	-39.40%	-343.70%	-44.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.27%	1.81%	-4.58%	-	-	-
FCF Yield	3.00%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-11.48%	-38.72%	-41.46%	0.00%	-0.94%	-